AA
SUPN icon

ALPS Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

ALPS Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,933
Closed -$300K – 954
2020
Q4 		$300K Sell
11,933
-363
-3% -$7.81K ﹤0.01% 714
2020
Q3 		$256K Buy
+12,296
New +$279K ﹤0.01% 741
2019
Q3 		– Sell
-10,004
Closed -$331K – 981
2019
Q2 		$331K Sell
10,004
-528
-5% -$18.1K ﹤0.01% 819
2019
Q1 		$369K Buy
10,532
+666
+7% +$24.8K ﹤0.01% 835
2018
Q4 		$328K Sell
9,866
-92,794
-90% -$3.99M ﹤0.01% 751
2018
Q3 		$5.17M Buy
102,660
+17,664
+21% +$872K 0.03% 160
2018
Q2 		$5.09M Buy
84,996
+5,167
+6% +$268K 0.03% 170
2018
Q1 		$3.66M Buy
79,829
+13,291
+20% +$555K 0.03% 169
2017
Q4 		$2.65M Buy
66,538
+5,263
+9% +$208K 0.02% 176
2017
Q3 		$2.45M Sell
61,275
-3,258
-5% -$141K 0.02% 175
2017
Q2 		$2.78M Buy
64,533
+3,950
+7% +$141K 0.02% 166
2017
Q1 		$1.9M Sell
60,583
-5,668
-9% -$152K 0.01% 182
2016
Q4 		$1.67M Sell
66,251
-15,859
-19% -$354K 0.01% 187
2016
Q3 		$2.03M Buy
82,110
+12,684
+18% +$287K 0.02% 182
2016
Q2 		$1.41M Buy
69,426
+14,407
+26% +$256K 0.01% 194
2016
Q1 		$839K Sell
55,019
-34,160
-38% -$446K 0.01% 193
2015
Q4 		$1.2M Sell
89,179
-11,381
-11% -$176K 0.01% 212
2015
Q3 		$14.1K Buy
100,560
+53,170
+112% +$989K 0.01% 191
2015
Q2 		$805K Buy
47,390
+26,119
+123% +$372K 0.01% 220
2015
Q1 		$257K Buy
+21,271
New +$201K ﹤0.01% 631

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ALPS Advisors's SUPN Position: Q1 2021 in Review

ALPS Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q1 2021, closing a stake of 11,933 shares — an estimated $300K sold.

ALPS Advisors first reported a position in SUPN in Q1 2015 and held it in 20 quarters. The position peaked at $5.17M in Q3 2018. 224 funds tracked by Wall St. Rank hold SUPN as of Q1 2021.

  • ALPS Advisors reported no remaining Supernus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • ALPS Advisors sold 11,933 Supernus Pharmaceuticals shares in Q1 2021, an estimated $300K.
  • ALPS Advisors first reported a position in Supernus Pharmaceuticals in Q1 2015 and held it in 20 quarters.
  • ALPS Advisors's Supernus Pharmaceuticals position peaked at $5.17M in Q3 2018.
  • 224 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2021.

Based on ALPS Advisors's 13F filing for Q1 2021, filed 7 May 2021.